AstraZeneca Pharma

Astrazeneca admits its Covishield vaccine can cause a rare side effect: Learn more about this condition.

COVID 19
Latest News
Spotlight

DCGI Gives Nod To AstraZeneca Pharma India To Import, Market Selumetinib Capsules

September 27, 2021 16:00
Healthwire Bureau

Drug firm AstraZeneca Pharma India has received import and market permission from the Indian drug regulator for Selumetinib capsules. AstraZeneca Pharma India said in a regulatory filing, the company has…

View Post

Input your search keywords and press Enter.

Menu

AstraZeneca Pharma

AstraZeneca Admits Rare Side Effect Risk In Covishield Vaccine, Sparks Public Concern

DCGI Gives Nod To AstraZeneca Pharma India To Import, Market Selumetinib Capsules

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?